Tue 22 Sep 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Updated Section | Month |
|---|---|---|---|
| Durvalumab | Imfinzi | 4.8. Undesirable effects | Nov,2022 |
| Dabigatran Etexilate Mesylate | Pradaxa | 4.8. Undesirable effects | May,2024 |
| Phenytoin | Accofil | 4.4 Special Warnings and Special Precautions for Use | May,2024 |
| Valproate Sodium | Depakine | 4.6. Fertility, pregnancy and lactation 5.3 Preclinical Safety Data | May, 2026 |
| Bemiparin Sodium | Hibor | 4.3 Contraindications | Mar,2023 |
| Zanubrutinib | Brukinsa | 2.3 Dosage Modifications for Drug Interactions | Mar,2023 |
| Furosemide | Lasix | 4.4 Special Warnings and Special Precautions for Use | Mar,2023 |
| Colistimethate Sodium | Colistin | 4.4 Special Warnings and Special Precautions for Use 4.8 Undesirable effects | Mar,2023 |
| Bosutinib | Bosulif | 4.8 Undesirable effects | Mar,2023 |
| Cabazitaxel | Jevtana | 4.8 Undesirable effects | Mar,2023 |
Last update date: 07/09/2026 at 07:51 AM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.